ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 72 filers reported holding ALBIREO PHARMA INC in Q1 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $870 | -100.0% | 40,260 | -56.7% | 0.00% | -100.0% |
| Q3 2022 | $1,802,000 | +143.2% | 93,063 | +149.6% | 0.00% | – |
| Q2 2022 | $741,000 | -47.4% | 37,289 | -23.6% | 0.00% | – |
| Q1 2022 | $1,410,000 | +29.2% | 48,807 | -7.8% | 0.00% | – |
| Q4 2021 | $1,091,000 | -37.4% | 52,937 | -6.5% | 0.00% | -100.0% |
| Q3 2021 | $1,743,000 | -11.8% | 56,631 | +0.8% | 0.00% | 0.0% |
| Q2 2021 | $1,976,000 | -6.5% | 56,158 | -6.3% | 0.00% | 0.0% |
| Q1 2021 | $2,113,000 | -62.0% | 59,933 | -59.6% | 0.00% | -50.0% |
| Q4 2020 | $5,558,000 | +123.9% | 148,172 | +99.2% | 0.00% | +100.0% |
| Q3 2020 | $2,482,000 | +47.7% | 74,376 | +17.2% | 0.00% | 0.0% |
| Q2 2020 | $1,681,000 | +99.6% | 63,449 | +23.4% | 0.00% | – |
| Q1 2020 | $842,000 | -13.9% | 51,419 | +33.7% | 0.00% | – |
| Q4 2019 | $978,000 | +25.5% | 38,467 | -1.1% | 0.00% | – |
| Q3 2019 | $779,000 | -35.5% | 38,913 | +3.9% | 0.00% | – |
| Q2 2019 | $1,207,000 | – | 37,449 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
| Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
| Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
| SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
| BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
| Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
| PA Capital LLC | 14,692 | $360,000 | 0.38% |
| Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
| Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |